Medical Examination and Clinical Diagnosis

Construction of risk prediction model for acute exacerbation in near future of elderly COPD patients in stable stage

  • Hui HAN ,
  • Ping XU ,
  • Weidong. SONG
Expand
  • Department of Respiratory and Critical Care Medicine,Peking University Shenzhen Hospital,Shenzhen 518000,China

Received date: 2023-07-02

  Online published: 2023-12-11

Abstract

Objective To investigate the risk factor of acute exacerbation in near future of elderly COPD patients in a stable stage and construct prediction model to provide more reference for early identification of high-risk groups of unplanned hospitalization and formulation of more active and effective intervention programs. Methods 654 elderly patients with COPD in stable stage were retrospectively chosen in the period from January 2018 to June 2022 in our hospital and grouped according to whether acute exacerbation occurred within 6 months of follow-up or not into with exacerbation group (134 cases) and non-exacerbation group (520 cases). Univariate and multivariate methods were used to analyze the independent influencing factors of short-term acute exacerbations risk in elderly COPD stable patients, and the prediction model based on the above independent influencing factors was constructed and the clinical efficacy of prediction model for short-term acute exacerbations risk was further evaluated. Results Univariate analysis showed that gender, body mass index, cough, FEV1, FVC, the frequency and duration of acute exacerbations in recent 1 year may be related to the occurrence of acute exacerbations in elderly patients with COPD in stable stage (P < 0.05). Multivariate analysis results of Logistic regression model showed that gender, body mass index, FEV1, FVC, the number and duration of acute exacerbations in recent 1 year were independent factors influencing the risk of acute exacerbations in elderly patients with COPD in stable stage (P < 0.05). The model equation was constructed according to the independent variable partial regression coefficient: near-term acute exacerbation risk [Logit (p/1-p)]=-2.981 + 0.642× sex -0.517× body mass index +0.316× the number of acute exacerbations in recent 1 year + 0.028× duration of acute exacerbation in recent 1 year -0.621×FEV1. ROC curve analysis results showed that the area under the curve for predicting the risk of acute exacerbation in near future of elderly COPD patients in stable stage was 0.84 (95%CI: 0.79 - 0.92), the optimal cut-off value was 0.23, and the sensitivity and specificity were 82.71% and 70.85%, respectively. Conclusion The occurrence of acute exacerbations in aged COPD patients in a stable stage was related to sex, body mass index, FEV1, FVC, the number and duration of acute exacerbations in recent 1 year and the prediction model based on the above independent factors can accurately predict the risk of acute exacerbations in the near future.

Cite this article

Hui HAN , Ping XU , Weidong. SONG . Construction of risk prediction model for acute exacerbation in near future of elderly COPD patients in stable stage[J]. The Journal of Practical Medicine, 2023 , 39(22) : 2984 -2988 . DOI: 10.3969/j.issn.1006-5725.2023.22.022

References

1 梁振宇,王凤燕,陈子正,等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学,2023,26(11):1287-1298.
2 MACLEOD M, PAPI A, CONTOLI M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact [J]. Respirology, 2021, 26(6): 532-551.
3 慢性阻塞性肺疾病急性加重诊治专家组. 慢性阻塞性肺疾病急性加重诊治中国专家共识(2023年修订版)[J]. 国际呼吸杂志,2023,43(2):132-149.
4 HOGEA S P, TUDORACHE E, FILDAN A P, et al. Risk factors of chronic obstructive pulmonary disease exacerbations [J]. Clin Respir J, 2020, 14(3): 183-197.
5 林铃,陈平. 慢性阻塞性肺疾病急性加重风险预测的研究进展[J]. 中国医师杂志,2022,24(7): 981-985.
6 中国老年医学学会呼吸病学分会慢性阻塞性肺疾病学组. 中国老年慢性阻塞性肺疾病临床诊治实践指南[J]. 中华结核和呼吸杂志,2020,43(2):100-119.
7 PAREKH T M, HELGESON E S, CONNETT J, et al. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial [J]. Ann Am Thorac Soc, 2022, 19(10): 1642-1649.
8 JO Y S, RHEE C K, KIM K J, et al. Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease [J]. Ther Adv Respir Dis, 2020, 14(1): 1753-1758.
9 王明航,蔡坤坤,施丁莉,等. 基于回归分析法建立慢性阻塞性肺疾病急性加重风险预测模型与验证[J]. 中华危重病急救医学,2021,33(1):64-68.
10 PENG J, CHEN C, ZHOU M, et al. A Machine-learning Approach to Forecast Aggravation Risk in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Clinical Indicators [J]. Sci Rep, 2020, 10(1): 3118-3125.
11 WANG Q, PEI G, CHEN L, et al. Factors affecting the length of stay and hospital readmission rates after an acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis [J]. Ann Transl Med, 2022, 10(4): 175-183.
12 YANG L, LI M, SHU J, et al. A Risk Prediction Model for Prolonged Length of Stay in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Study of 225 Patients in a Single Center in Kunming, China [J]. Med Sci Monit, 2022, 28(2): e934392.
13 YILMAZ C, ?ZKAN S, ERER O F. Risk assessment and rate of readmission within 30 days of discharge after hospitalization for acute exacerbation of chronic obstructive pulmonary disease [J]. Tuberk Toraks, 2021, 69(3): 328-337.
14 GU Y, YE X, LIU Y, et al. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Respir Res, 2021, 22(1): 176-183.
15 WANG J, DING Y M. Prevalence and risk factors of pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease and its impact on outcomes: a systematic review and meta-analysis [J]. Eur Rev Med Pharmacol Sci, 2021, 25(6): 2604-2616.
16 JUNG Y J, KIM E J, HEO J Y, et al. Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study [J]. Int J Environ Res Public Health, 2022, 19(5): 2823-2830.
17 ZHOU C, YI Q, GE H, et al. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China [J]. Thromb Haemost, 2022, 122(7): 1177-1185.
18 DONG H, HAO Y, LI D, et al. Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study [J]. Int J Chron Obstruct Pulmon Dis, 2020, 15(9): 2249-2256.
19 ADIBI A, SIN DD, SAFARI A, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study [J]. Lancet Respir Med, 2020, 8(10): 1013-1021.
20 ZHANG R, LU H, CHANG Y, et al. Prediction of 30-day risk of acute exacerbation of readmission in elderly patients with COPD based on support vector machine model [J]. BMC Pulm Med, 2022,22(1):292.
21 WANG Z, LOCANTORE N, HALDAR K, et al. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis [J]. Am J Respir Crit Care Med, 2021, 203(12): 1488-1502.
22 HUEBNER S T, HENNY S, GIEZENDANNER S, et al. Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers [J]. Respiration, 2022, 101(5): 441-454.
23 JACOBSEN P A, KRAGHOLM K H, TORP-PEDERSEN C, et al. Employment Status, Readmission and Mortality After Acute Exacerbation of COPD. Janssen DJA, Spruit MA, Weinreich UM[J]. Int J Chron Obstruct Pulmon Dis, 2021,16:2257-2265.
Outlines

/